AdvaMed 2002 Annual Meeting In Brief
This article was originally published in The Gray Sheet
Executive Summary
Meet Mark Kramer: Former CDRH staff college director becomes FDA's point-of-contact for combination products Feb. 25. Working within the FDA ombudsman's office, Kramer will canvass opinions from internal and external stakeholders, advocate more complex reviews of combination products, and navigate firms' requests for designation. At the AdvaMed 2002 Annual Meeting in Carlsbad, California, Center for Biologics Evaluation & Research Deputy Director Jesse Goodman outlined Kramer's role - to "deal with specific problems, interact with manufacturers, and sort of do a better job of bringing all of us to the table to update intercenter agreements." In addition, Kramer will help develop standard operating procedures for intercenter collaboration and consultation. As the first in a series of public meetings devoted to jurisdictional issues, FDA anticipates hosting a May public meeting on tissue-engineered devices. Kramer's background includes experience working in the device industry and CDRH's Office of Device Evaluation...
You may also be interested in...
Federal Diagnostic Research Funds Will Head Off Future Epidemics – CBER
CBER plans to create financial incentives for companies to develop diagnostic technologies for pathogens before the diseases become prevalent, according to center director Jesse Goodman
Federal Diagnostic Research Funds Will Head Off Future Epidemics – CBER
CBER plans to create financial incentives for companies to develop diagnostic technologies for pathogens before the diseases become prevalent, according to center director Jesse Goodman
Kramer Continues Combo Product Stewardship, Fosters Intercenter Consults
FDA Office of Combination Products Director Mark Kramer will be assisted by Suzanne O'Shea, who is leaving the Office of the Ombudsman to serve as product assignment officer